Rangan V

ORCID: 0000-0001-9804-958X · 1 paper in corpus
2018
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association ·doi:10.1016/j.cgh.2018.04.009

Background & aimsA high proportion of patients with irritable bowel syndrome (IBS) respond to placebo in clinical trials (estimated at about 40%). We aimed to identify factors that contribute to the high placebo response rate using data fro…